Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis
Journal of Pharmacy and Pharmacology · 01.04.2023 · 75 (4) · 533-543
DOI: 10.1093/jpp/rgad013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.04.2023. Verfasst von Rasha E Mostafa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colorectal Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Objective
Ulcerative colitis (UC) is a relapsing inflammatory health state posing significant worldwide problems. Ezetimibe is a cholesterol-lowering drug having anti-inflammatory and pleiotropic properties.
Methods
Twenty-four rats were classified into four groups (n = 6). Group (I) was considered negative control. Acetic acid (AA) was instilled intrarectally in groups (II–IV). Group (II) was considered UC-control. Groups (III and IV) were orally treated with Ezetimibe (5 and 10 mg/kg/day; 14 days). Key finding AA installation resulted in severe macroscopic colonic lesions associated with elevations in the relative colon weight, the wet weight/length ratio and oxidative stress markers in the colorectum tissues. UC-control rats showed significantly elevated colorectal tissue CXCL10 and STAT3 gene expression. Akt, phosphorylated Akt, phosphorylated STAT3, TNF-α, IL-6 and NF-κB were expressively upregulated in the UC-control group. AA installation also resulted in significant histopathological alterations in the colorectum tissues of UC-control rats along with increasing the colorectal tissues’ immunohistochemical iNOS expression. Collectively, these data suggest activation of the Akt/NF-κB/STAT3/CXCL10 signaling axis. Ezetimibe treatment significantly ameliorated all the aforementioned parameters.
Conclusion
This is the first study to elucidate the modulatory actions of Ezetimibe against oxidative stress and inflammation associated with AA-induced UC in rats. Ezetimibe treatment mitigates UC via downregulation of the Akt/NF-κB/STAT3/CXCL10 signaling axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.
ORCID-Profile: Rasha E Mostafa, Rehab F Abdel-Rahman
Zitieren
APA
Mostafa, R. E., & Abdel-Rahman, R. F. (2023). Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis. Journal of Pharmacy and Pharmacology, 75(4), 533-543. https://doi.org/10.1093/jpp/rgad013
Vancouver
Mostafa RE, Abdel-Rahman RF. Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis. Journal of Pharmacy and Pharmacology. 2023;75(4):533-543. doi:10.1093/jpp/rgad013
BibTeX
@article{Mostafa2023,
author = {Mostafa, Rasha E and Abdel-Rahman, Rehab F},
title = {Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
volume = {75},
number = {4},
pages = {533--543},
doi = {10.1093/jpp/rgad013}
}
EUVIMED